Aandeel 300878 ZHEJIANG WECOME PHARMACEUTICAL COMPANY LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Zhejiang Wecome Pharmaceutical Company Limited

Aandelen

300878

CNE1000047P9

slotkoers Shenzhen S.E.
Andere beurzen
 00:00:00 21-06-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
14,74 CNY +2,01% Intraday-grafiek van Zhejiang Wecome Pharmaceutical Company Limited -1,99% -41,90%
28/04 Zhejiang Wecome Pharmaceutical Company Limited meldt winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024 CI
19/04 Zhejiang Wecome Pharmaceutical Company Limited rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!
Gratis inschrijven
Zhejiang Wecome Pharmaceutical Company Limited Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Zhejiang Wecome Pharmaceutical Company Limited's Equity Buyback Plan announced on February 7, 2024.
Zhejiang Wecome Pharmaceutical Company Limited's Equity Buyback announced on February 7, 2024, has closed with 2,739,026 shares, representing 1.89% for CNY 50 million.
Zhejiang Wecome Pharmaceutical Company Limited announces an Equity Buyback for CNY 50 million worth of its shares.
Zhejiang Wecome Pharmaceutical Company Limited authorizes a Buyback Plan.
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Certain A Shares of Zhejiang Wecome Pharmaceutical Company Limited are subject to a Lock-Up Agreement Ending on 24-AUG-2023.
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022
Zhejiang Wecome Pharma to Issue $95 Million Convertible Bonds
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Hangzhou Haishan Pharmaceutical Equipment Co., Ltd. announced that it expects to receive CNY 20 million in funding from Zhejiang Wecome Pharmaceutical Company Limited
Zhejiang Wecome Pharmaceutical Company Limited Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on 17 June 2022
Zhejiang Wecome Pharmaceutical Company Limited Approved Cash Dividend for the Year 2021
Zhejiang Wecome Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2021
Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 300878
  4. Nieuws Zhejiang Wecome Pharmaceutical Company Limited
  5. Andere talen